Ann Arbor, MINCT06675344Now EnrollingIRB Ready

Systemic Sclerosis (SSc) Clinical Trial in Ann Arbor, MI

Access cutting-edge systemic sclerosis (ssc) treatment through this clinical trial at a research site in Ann Arbor. Study-provided care at no cost to qualified participants.

Sponsored by Robyn T. Domsic, MD, MPH

Quick Self-Assessment

See if you qualify for this Ann Arbor location

Preparing your pre-screening questions…

Expert Care in Ann Arbor

Access systemic sclerosis (ssc) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related systemic sclerosis (ssc) treatment provided free

Apply for This Ann Arbor Location

Check if you qualify for this systemic sclerosis (ssc) clinical trial in Ann Arbor, MI

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Ann Arbor

    Convenient for MI residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Ann Arbor site if eligible
  4. 4Begin participation

About This Systemic Sclerosis (SSc) Study in Ann Arbor

The purpose of this study it to test the efficacy of a wearable device to improve symptom management and maximize qualify of life in systemic Sclerosis (SSc) patients in a randomized trial. Specifically, we will evaluate if the Apollo Neuro device may improve the two specific symptoms highest ranked by patients as affecting qualify of life (fatigue, Raynaud phenomenon) as co-primary outcomes.

Sponsor: Robyn T. Domsic, MD, MPH

Who Can Participate

Inclusion Criteria

Age ≥ 18 years
Ability to provide written informed consent,
Diagnosis of SSc, as defined by the 2013 ACR/EULAR classification of SSc64 with a positive ANA
Baseline score ≥55 on the FACIT-Fatigue scale,
Presence of Raynaud phenomenon with ASRAP-SF severity of T-score ≥40,
Steady daily doses and any immunosuppressive medication, vasodilators or other medications used to treat pulmonary hypertension, antidepressants and anxiolytic use for 4 weeks prior to baseline
Currently owns and operates an iOS or Android smart phone regularly
Ability to comply with the clinical visits schedule and the study-related procedures.

Exclusion Criteria

History of sympathectomy or stellate ganglion block
History of Botox injections to the digits within the last 3 months
Diabetes mellitus
Major surgery within 8 weeks
Hospitalization for any reason within four weeks of the study baseline visit
Active malignancy
Pregnant or breastfeeding women,
End-stage renal disease (estimated glomerular filtration rate \< 15 mL/min/1.73m2) or on dialysis,
Hepatic insufficiency as defined by function worse than Child-Pugh Class B
Medication exclusions:
actively prescribed standing doses of beta-blockers,
actively prescribed standing doses of sedatives, hypnotics, opioids, benzodiazepines or anti-psychotic medications.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Ann Arbor?

Yes, this clinical trial (NCT06675344) has an active research site in Ann Arbor, MI that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Systemic Sclerosis (SSc) Treatment Options in Ann Arbor, MI

If you're searching for systemic sclerosis (ssc) treatment options in Ann Arbor, MI, this clinical trial (NCT06675344) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Ann Arbor research site is actively enrolling participants for this clinical trial. You'll receive care from experienced systemic sclerosis (ssc) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all systemic sclerosis (ssc) clinical trials near you to find additional studies recruiting in your area.

More Heart Attack Trials in Ann Arbor, MI

See all heart attack clinical trials recruiting in Ann Arbor — not just this study.

Browse Heart Attack Trials in Ann Arbor →

Browse More Trials by Condition

Heart Attack TrialsScleroderma TrialsInterstitial Cystitis TrialsMyocardial Infarction TrialsAll Conditions →

Ready to Join in Ann Arbor?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Ann Arbor, MI